A four-year study at Jerusalem’s Hadassah hospital of the stem cell treatment from Israel’s Brainstorm has been shown to inhibit the progression of the fatal neurological disease ALS (Lou Gehrig’s) in 87 percent of 26 patients.

http://www.jpost.com/Business-and-Innovation/Health-and-Science/Optimistic-results-for-Phase-ALS-treatment-at-Jerusalem-hospital-441407